LIFS / Life Stem Genetics Inc. - SEC-arkiveringar, Årsredovisning, Fullmaktsutlåtande

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 333-183814 Life Stem Genetics Inc. (Exact name of registrant as specified in

Quarterly Report -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 or [ ]TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-183814 LIFE STEM GE

EX-10.9

Exhibit 10.9

Quarterly Report -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2013 or [ ]TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-183814 LIFE STEM

EX-10.8

Exhibit 10.8

EX-10.1

Exhibit 10.1

EX-10.3

Exhibit 10.3

EX-10.6

Exhibit 10.6

EX-10.4

Exhibit 10.4

Unregistered Sales of Equity Securities, Completion of Acquisition or Disposition of Assets -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest event Reported): September 19, 2013 LIFE STEM GENETICS INC. (Exact name of registrant as specified in its charter) Nevada 333-183814 80-0832746 (State or other jurisdiction of (Commission File Number)

SCHEDULE A THE SELLING SHAREHOLDERS

Exhibit 2.2 THIS AMENDING AGREEMENT is made as of the 19th day of September, 2013. AMONG: LIFE STEM GENETICS INC., a State of Nevada corporation with an office at 1504 Bay Road, Suite 924, Miami, Florida 33139 (“Pubco”) AND: LIFE STEM GENETICS, INC., a State of South Dakota corporation with an office at 433 North Camden Drive, Suite 400, Beverly Hills, CA 90210 (“Priveco”) AND: THE UNDERSIGNED SHA

EX-10.5

Exhibit 10.5

EX-10.2

Exhibit 10.2

EX-3.1

EX-3.1 2 ex3-1.htm Exhibit 3.1

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events

8-K 1 g7069.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 16, 2013 Life Stem Genetics Inc. (Exact name of registrant as specified in its charter) Nevada 333-183814 80-0832746 (State or other jurisdiction of incorpora

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2013 MIAMI DAYS CORP. (Exact name of registrant as specified in its charter) Nevada 333-183814 80-0832746 (State of other jurisdiction of incorporation) (Commission File Num

- CONVERTED BY EDGARWIZ

Converted by EDGARwiz U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 333-183814 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [x] Form 10-Q [ ] From N-SAR For Period Ended: [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Tr